A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs

for donors, related donors giving peripheral blood stem cells (pbsc) to a sibling, for recipients, acute myelogenous leukemia (aml), acute lymphoblastic leukemia (all), myelodysplastic syndrome (mds), chronic myelogenous leukemia (cml), non-hodgkins lymphoma (nhl), hodgkins disease (hd), chronic lymphocytic leukemia (cll), interventional, phase2